Ouro Fino Saude Animal Participacoes SA operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Ouro Fino Saude Animal Participacoes SA with three other pharmaceutical manufacturers in Latin America: Laboratorios Richmond SACIF of ARGENTINA (2019 sales of 3.90 billion Argentinian Pesos [US$53.44 million] of which 66% was Private Market), Fleury SA (2.91 billion Brazilian Reals [US$529.95 million] of which 84% was Diagnostic Medicine), and Instituto Hermes Pardini SA (1.35 billion Brazilian Reals [US$246.93 million] of which 100% was auxiliary diagnostic support services).

Sales Analysis. During the year ended December of 2019, sales at Ouro Fino Saude Animal Participacoes SA were 619.59 million Brazilian Reals (US$113.02 million). This is an increase of 5.2% versus 2018, when the company's sales were 589.22 million Brazilian Reals. This was the third consecutive year of growth at Ouro Fino Saude Animal Participacoes SA. Sales of Internacional Operations saw an increase that was more than double the company's growth rate: sales were up 16.8% in 2019, from 55.02 million Brazilian Reals to 64.27 million Brazilian Reals. Ouro Fino Saude Animal Participacoes SA also saw significant increases in sales in Pets (up 16.7% to 88.23 million Brazilian Reals) .